Drug studies in humans
Last updated: 2024 Apr 18
Total hit(s): 6542
S.No.
1
38512394
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38575149
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
3
38346223
Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
4
38584118
Comparison of T cells mediated immunity and side effects of mRNA vaccine and conventional COVID-19 vaccines administrated in Jordan.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
5
38073167
Assessing the quantity of neuropeptide Y in the serum of patients referred to Baqiyatallah Hospital with covid-19 concerning inflammatory factors following steroid therapy.
Acta Neurol Taiwan
2024 Dec 30
1
6
38377136
Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies.
Emerg Microbes Infect
2024 Dec
5.84
1
7
38183475
Development of multiplex allele-specific RT-qPCR assays for differentiation of SARS-CoV-2 Omicron subvariants.
Appl Microbiol Biotechnol
2024 Dec
3.82
1
8
38524302
Alternative genome sequencing approaches of SARS-CoV-2 using Ion AmpliSeq Technology.
MethodsX
2024 Jun
1
9
38379717
An efficient ELISA protocol for measurement of SARS-CoV-2 spike-specific IgG in human plasma and serum samples.
MethodsX
2024 Jun
1
10
38574505
Diverse pro-inflammatory ability of mutated spike protein derived from variant strains of SARS-CoV-2.
Cytokine
2024 Jun
2.88
1
11
38431405
Fucoidan from Ascophyllum nodosum and Undaria pinnatifida attenuate SARS-CoV-2 infection in vitro and in vivo by suppressing ACE2 and alleviating inflammation.
Carbohydr Polym
2024 May 15
6.23
1
12
37929506
Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia.
Med Gas Res
2024 Apr-Jun
4
1
13
38591881
The potentiality of bacteria to drive SARS-CoV-2 mutation.
mBio
2024 Apr 9
6.5
1
14
38599653
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.
RMD Open
2024 Apr 9
6.1
1
15
38589848
Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.
Virol J
2024 Apr 9
2.45
1
16
38592189
Prediction of deleterious non-synonymous SNPs of TMPRSS2 protein combined with Molecular Dynamics Simulations and free energy analysis to identify the potential peptide substrates against SARS-CoV-2.
J Biomol Struct Dyn
2024 Apr 9
3.22
1
17
38589755
Dynamic Patterns and Predominance of Respiratory Pathogens Post-COVID-19: Insights from a Two-Year Analysis.
J Epidemiol Glob Health
2024 Apr 8
3.7
1
18
38593595
Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
Virology
2024 Apr 8
2.819
1
19
38587722
Analysis of SARS-CoV-2 omicron mutations that emerged during long-term replication in a lung cancer xenograft mouse model.
Virus Genes
2024 Apr 8
4.2
1
20
38590219
Experience of treatment in critical Guillain-Barre Syndrome case after COVID-19 vaccination.
Int J Dev Neurosci
2024 Apr 8
1
21
38581072
Immunoglobulins in COVID-19 pneumonia: from the acute phase to the recovery phase.
Eur J Med Res
2024 Apr 6
1.71
1
22
38583778
Evidence from Whole Genome Sequencing of Aerosol Transmission of SARS-CoV-2 almost Five Hours after Hospital Room Turnover.
Am J Infect Control
2024 Apr 5
2.03
1
23
38582657
A comparative analysis of TCR immune repertoire in COVID-19 patients.
Hum Immunol
2024 Apr 5
1.95
1
24
38578389
COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report.
J Clin Immunol
2024 Apr 5
3.89
1
25
38575973
Green chemometric-assisted UV-spectrophotometric methods for the determination of favipiravir, cefixime and moxifloxacin hydrochloride as an effective therapeutic combination for COVID-19; application in pharmaceutical form and spiked human plasma.
BMC Chem
2024 Apr 5
1